LeMaitre Vascular (LMAT) Expected to Announce Quarterly Earnings on Thursday

LeMaitre Vascular (NASDAQ:LMAT) will likely be releasing its earnings data after the market closes on Thursday, February 27th. Analysts expect LeMaitre Vascular to post earnings of $0.49 per share and revenue of $55.99 million for the quarter. Persons interested in listening to the company’s earnings conference call can do so using this link.

LeMaitre Vascular Trading Up 2.5 %

Shares of NASDAQ LMAT opened at $102.03 on Tuesday. The stock has a market cap of $2.29 billion, a P/E ratio of 55.75, a PEG ratio of 2.22 and a beta of 0.96. LeMaitre Vascular has a 12-month low of $61.09 and a 12-month high of $109.58. The business’s fifty day simple moving average is $96.23 and its 200-day simple moving average is $94.42.

Analysts Set New Price Targets

Several equities analysts have issued reports on LMAT shares. Barrington Research raised their price objective on LeMaitre Vascular from $92.00 to $93.00 and gave the stock an “outperform” rating in a report on Friday, November 1st. StockNews.com downgraded shares of LeMaitre Vascular from a “buy” rating to a “hold” rating in a research report on Friday, December 13th. Oppenheimer restated an “outperform” rating and set a $93.00 price objective (up from $90.00) on shares of LeMaitre Vascular in a research report on Friday, November 1st. Finally, Wells Fargo & Company started coverage on LeMaitre Vascular in a report on Thursday, February 13th. They issued an “equal weight” rating and a $95.00 price target for the company. Three investment analysts have rated the stock with a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $94.63.

About LeMaitre Vascular

LeMaitre Vascular, Inc develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature.